Skip to content
healthcare.dev

Cladosporium cladosporioides

NDC 49643-178, Cladosporium cladosporioides, liquid, from Allermed Laboratories, Inc..

Product NDC
49643-178
Status
Listed
Labeler
Allermed Laboratories, Inc.
Dosage form
LIQUID
Route
PERCUTANEOUS, SUBCUTANEOUS
Product type
NON-STANDARDIZED ALLERGENIC
Marketing category
BLA
Application
BLA102211
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/49643-178 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CLADOSPORIUM CLADOSPORIOIDES.1 g/mL

Pharmacologic classes

Allergens [CS]; Cell-mediated Immunity [PE]; Fungal Proteins [CS]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Non-Standardized Fungal Allergenic Extract [EPC]

Package NDCNDC-11Package
49643-178-05496430178055 mL in 1 VIAL, MULTI-DOSE (49643-178-05)
49643-178-104964301781010 mL in 1 VIAL, MULTI-DOSE (49643-178-10)
49643-178-304964301783030 mL in 1 VIAL, MULTI-DOSE (49643-178-30)
49643-178-504964301785050 mL in 1 VIAL, MULTI-DOSE (49643-178-50)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 49643-178 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/49643-178 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 49643-178. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.